Ilan Ganot - 27 Jan 2026 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director
Signature
/s/ Kimberly Cornwell as attorney-in-fact for Ilan Ganot
Issuer symbol
SLDB
Transactions as of
27 Jan 2026
Net transactions value
$0
Form type
4
Filing time
02 Feb 2026, 20:07:46 UTC
Previous filing
06 Jan 2026
Next filing
06 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ganot Ilan Director C/O SOLID BIOSCIENCES INC., 500 RUTHERFORD AVENUE, THIRD FLOOR, CHARLESTOWN /s/ Kimberly Cornwell as attorney-in-fact for Ilan Ganot 02 Feb 2026 0001727460

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLDB Common Stock Options Exercise +15,000 +86% 32,476 31 Jan 2026 Wife F1
holding SLDB Common Stock 99,297 27 Jan 2026 Direct F2
holding SLDB Common Stock 19,394 27 Jan 2026 See Footnote 3 F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Employee Stock Option (Right to Buy) Award $0 +70,900 $0.000000 70,900 29 Jan 2026 Common Stock 70,900 $6.60 Wife F4
transaction SLDB Restricted Stock Units Award $0 +35,450 $0.000000 35,450 29 Jan 2026 Common Stock 35,450 Wife F1, F5
transaction SLDB Restricted Stock Units Options Exercise $0 -15,000 -25% $0.000000 45,000 31 Jan 2026 Common Stock 15,000 Wife F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2 Represents 95,255 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.
F3 Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.
F4 This option was granted on January 29, 2026 (the "2026 Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary.
F5 The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary.
F6 On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 60,000 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary